AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition ...

Globus Medical went into 2025 with a strong foothold in spine and orthopedics, and it’s well-positioned for the next year. Here are 10 key updates: 1. Globus Medical introduced its DuraPro drill with ...

Across the recent three months, 8 analysts have shared their insights on Globus Medical (NYSE:GMED), expressing a variety of opinions spanning from bullish to bearish. The table below provides a ...

What Happened? Shares of medical device company Globus Medical (NYSE:GMED) jumped 2.6% in the afternoon session after RBC Capital raised its price target on the stock to $100 from $92, while keeping ...

Globus Medical GMED has seen impressive momentum in the past year, with its shares soaring 62.1%. It has significantly outperformed the industry’s 7.3% rise and the S&P 500 composite’s 24.8% gain.

Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...

Across the recent three months, 11 analysts have shared their insights on Globus Medical (NYSE:GMED), expressing a variety of opinions spanning from bullish to bearish. Summarizing their recent ...

In recent weeks, Needham & Co.'s team of medtech analysts met with a series of investors across several regions of the United States. We previously shared their insights on AtriCure, Haemonetics, ...

The latest price target for Globus Medical (NYSE:GMED) was reported by JMP Securities on May 27, 2025. The analyst firm set a price target for $0.00 expecting GMED to fall to within 12 months (a ...

Globus Medical, a specialist in medical devices with a focus on the spine market, has demonstrated impressive performance in recent quarters despite facing some integration challenges earlier in the ...

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced a new leadership structure to enhance organizational alignment and ...